Mingqian Feng

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 4

Top Topics

Small Cell Lung Cancer

Anaerobic Digestion

Top Venues

Biomaterials research

Molecular cancer therapeutics

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Ke Wang, Yuankui Zhu, Mengqing Li, Yaxi Yang, Dianbao Zuo, Junfeng Sheng, Xinhai Zhang, Wei Wang, Ping Zhou, Mingqian Feng
Genetically Modified Hepatocytes Targeting Bilirubin and Ammonia Metabolism for the Construction of Bioartificial Liver System. Biomaterials research 28 (2024)
Ke Wang, Yuankui Zhu, Mengqing Li, Yaxi Yang, Dianbao Zuo, Junfeng Sheng, Xinhai Zhang, Wei Wang, Ping Zhou, Mingqian Feng
Genetically Modified Hepatocytes Targeting Bilirubin and Ammonia Metabolism for the Construction of Bioartificial Liver System. Biomaterials research 28 (2024)
Xin Chen, Norhan Amar, Yuankui Zhu, Chunguang Wang, Chunjiao Xia, Xiaoqing Yang, Dongde Wu, Mingqian Feng
Combined DLL3-targeted bispecific antibody with PD-1 inhibition is efficient to suppress small cell lung cancer growth. Journal for immunotherapy of cancer 8 (1) (2021)
Xin Chen, Yanmin Chen, Rong Liang, Lanxin Xiang, Jingwen Li, Yuankui Zhu, Huixia He, Le Huang, Dianbao Zuo, Weihang Li, Xinjun Liang, Shuang Dong, Sheng Hu, Mitchell Ho, Mingqian Feng
Combination Therapy of Hepatocellular Carcinoma by GPC3-Targeted Bispecific Antibody and Irinotecan is Potent in Suppressing Tumor Growth in Mice. Molecular cancer therapeutics (2021)